| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.2M | +220.6% |
| Cost of Revenue | $30.8M | +6.7% |
| Gross Profit | -$9.6M | +57.0% |
| R&D Expense | $13.2M | +43.9% |
| SG&A Expense | $24.7M | -41.8% |
| Operating Income | -$47.4M | +35.8% |
| Pre-tax Income | -$64.1M | +37.1% |
| Income Tax | $4K | +103.4% |
| Net Income | -$64.1M | +37.0% |
| EPS (Basic) | -$6.76 | +86.9% |
| EPS (Diluted) | -$6.76 | +86.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.9M | +213.6% |
| Accounts Receivable | $3.9M | +623.5% |
| Inventory | $39.1M | -6.6% |
| Current Assets | $59.8M | +12.0% |
| Total Assets | $117.9M | +25.6% |
| Current Liabilities | $38.9M | -14.1% |
| Total Liabilities | $74.8M | +51.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.6M | +25.3% |
| Capital Expenditures | $603K | -85.2% |
| Investing Cash Flow | $9.8M | +341.8% |
| Financing Cash Flow | $32.0M | +56.5% |
| Free Cash Flow | -$36.2M | +30.0% |
| $43.0M |
| -2.8% |